Tailoring chemo doses: a new hope for GI cancer patients?
NCT ID NCT05780684
First seen Oct 31, 2025 · Last updated May 14, 2026 · Updated 30 times
Summary
This study tests a new way of giving chemotherapy to people with advanced gastrointestinal cancers, like colorectal or stomach cancer. The approach adjusts the dose of one chemo drug (5-FU) based on how well each patient tolerates the initial dose, aiming to give a stronger, more effective dose to those who can handle it. About 36 participants will receive this personalized regimen to see if it's feasible and improves treatment response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dartmouth-Hitchcock Medical Center
RECRUITINGLebanon, New Hampshire, 03756, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.